Con Konstantopoulos, Akesa

Con konstantopoulos

Co-Founder and Co-CEO

Connect on LinkedIn

With over two decades in the pharmaceutical industry, Con Konstantopoulos has deep knowledge and experience in managing international pharmaceutical supply chains.

  • Comparator sourcing: the hidden complexity behind a single IMP line item

    An estimated two-thirds of clinical trials involve a comparator drug or co-therapy.

  • Akesa supports inclusion at FIDA 2024 Grand Final Day

    Akesa has announced its support for The Football Integration Development Association (FIDA) 2024 Grand Final Day.

  • Federal Budget 2024-25: Key outcomes for Australian clinical trial sector

    The Australian Federal Budget for FY24-25 has outlined significant funding and initiatives to support the health sector, with a strong focus on clinical trials and medical research. Explore the key outcomes that will impact the clinical trial sector in Australia.

    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.